Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial. [electronic resource]
Producer: 20200212Description: 2375-2380 p. digitalISSN:- 1435-702X
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Diabetic Retinopathy -- complications
- Double-Blind Method
- Drug Therapy, Combination
- Erythropoietin -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Macula Lutea -- pathology
- Macular Edema -- diagnosis
- Male
- Middle Aged
- Tomography, Optical Coherence -- methods
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.